TICKERNERD
Menu
SINTSINTHealthcare · Medical Devices

SINT Stock Forecast: SINTX Technologies, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$1.77
+4.12% on the day

The 4 Wall Street analysts covering SINTX Technologies, Inc. hold a median 12-month price target of $9.25 — +422.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 20 of 100 as at 1 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$10.8M
Ticker Nerd rank
20 / 100
Median analyst target
$9.25
Analysts covering
4
Total return, dividends reinvested
1W
+14.2%
1M
−6.8%
YTD
−54.1%
1Y
−26.2%
From 52W high
−67.9%
From 52W low
+26.4%
$1.40
$5.51
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SINT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SINTX Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
20 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
93
Size
92
Issuance
49
Revisions
37
Growth
27
Momentum
11
Quality
7
Value
6
Volatility
4

Accruals (93): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (4): The share price moves around a lot.

The rank is the raw material. Whether the rules would actually own SINTX Technologies, Inc. — and when they’d sell — is the membership.

Wall Street

SINT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SINT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$2.00$4.00$6.00$8.00$10.00$12.00Oct 25Jan 26Apr 26Jul 26SINTHigh $12.00Median $9.25Low $6.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says4 analysts
4 Buy0 Hold0 Sell
Low $6.00Median $9.25High $12.00

The green dot is the last close — the median target sits +422.6% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
4 June 2026Maxim GroupReinstatesBuy$6.00
20 May 2026HC Wainwright & Co.ReiteratesBuy—
13 Apr 2026HC Wainwright & Co.InitiatesBuy—
8 Apr 2026Ascendiant CapitalMaintainsBuy—
8 Dec 2025Ascendiant CapitalMaintainsBuy—
22 Sept 2025Ascendiant CapitalMaintainsBuy—
30 May 2025Ascendiant CapitalMaintainsBuy—
21 Apr 2025Ascendiant CapitalMaintainsBuy—
5 Feb 2024Maxim GroupDowngradeHold—
3 Apr 2023Maxim GroupMaintainsBuy—
15 Feb 2023Maxim GroupMaintainsBuy—
20 Jan 2023Maxim GroupMaintainsBuy—
3 Aug 2020Maxim GroupUpgradeBuy$4.50
12 Sept 2019Ascendiant CapitalInitiatesBuy—
11 Sept 2019Ascendiant CapitalInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

SINT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

SINTX Technologies, Inc. (SINT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.3×

Cheaper than 78% of US stocks

Price / sales
10.5×

Cheaper than 13% of US stocks

Price / book
7.8×

Cheaper than 13% of US stocks

EV / EBITDA
−0.8×

Cheaper than 67% of US stocks

Growth & margins
Revenue growth (YoY)
3.0%

Higher than 37% of US stocks

Earnings growth (YoY)
3.1%

Higher than 41% of US stocks

Gross margin
21.3%

Higher than 24% of US stocks

Operating margin
−830.0%

Higher than 6% of US stocks

Net margin
23.6%

Higher than 85% of US stocks

Returns & dividend
Return on equity
−311.4%

Higher than 4% of US stocks

Return on assets
−73.9%

Higher than 5% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

SINT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
SINTSINTX Technologies, Inc.$10.8M
20
MODDModular Medical, Inc.$12.9M
11
PMIPicard Medical, Inc.$9.0M
43
VNRXVolitionRX Ltd.$8.6M
25
HSCSHeartSciences, Inc.$8.5M
31
IRIXIRIDEX Corp.$14.1M
98
NMTCNeuroOne Medical Technologies Corp.$14.3M
23
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SINT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest SINT news & analysis

SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast

GlobeNewsWire · 28 July 2026neutral

SINTX Technologies announced it will release its second quarter 2026 financial results after market close on August 11, 2026, and will host a conference call and webcast at 4:30 p.m. that day.

Why it matters — The announcement provides the date and time for SINTX's quarterly earnings report, allowing investors and analysts to prepare for the release and subsequent conference call.

FAQ

Frequently asked questions about SINT stock

What is the SINT stock price forecast for 2026-2027?

The 4 Wall Street analysts covering SINTX Technologies, Inc. have a median 12-month price target of $9.25, with estimates ranging from $6 to $12. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SINT stock a buy right now?

Of the 4 analysts covering SINTX Technologies, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SINTX Technologies, Inc. 20 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SINT?

As at 1 Aug 2026, SINTX Technologies, Inc. ranks 20 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (93 of 100).

Will SINT stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +422.6% from the last close, and Ticker Nerd's factor model ranks SINTX Technologies, Inc. 20 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SINT stock forecast for 2030?

No analyst covering SINTX Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SINT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $6 to $12 over the next 12 months.

How has SINT stock performed over the past year?

SINTX Technologies, Inc. returned -26.2% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does SINTX Technologies, Inc. do?

Sintx Technologies Inc. is an advanced ceramics company specializing in the research, development, and commercialization of silicon nitride-based medical devices and biomaterials.

What is the latest news on SINT?

The most recent item we track (GlobeNewsWire, 28 July 2026): "SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast". SINTX Technologies announced it will release its second quarter 2026 financial results after market close on August 11, 2026, and will host a conference call and webcast at 4:30 p.m. that day.

Company

About SINTX Technologies, Inc.

Sintx Technologies Inc. is an advanced ceramics company specializing in the research, development, and commercialization of silicon nitride-based medical devices and biomaterials. It manufactures solid and porous silicon nitride products, silicon nitride powder, coatings, and composite materials including polyether ether ketone and polyetherketoneketone for biomedical, technical, and antipathogenic applications. The company offers innovative solutions such as the FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System and OsseoSculpt biologic, which feature pro-osteogenic, bacteriostatic, and enhanced imaging properties. Sintx Technologies Inc. also develops antipathogenic fibrous materials and fabrics for medical textiles, wound dressings, filtration, PPE, and high-touch surfaces, supported by composition and method patents. Recent advancements include the SiN/PEEK compound produced via partnerships for AI-assisted, 3D-printed patient-specific implants targeting orthopedic, spine, and reconstructive surgery markets. Founded in 1996 and headquartered in Salt Lake City, Utah, Sintx Technologies Inc. focuses on infection-resistant devices, polymer composites, and licensing opportunities in the medical device sector.

CEO Mr. Eric K. Olson · 32 employees · United States · https://www.sintx.com